Evaluation to Assess Safety and Tolerability of DM199 in Subjects With Acute Ischemic Stroke

NCT03290560 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

92

Enrollment

INDUSTRY

Sponsor class

Conditions

Acute Ischemic Stroke

Interventions

DRUG: Recombinant human tissue kallikrein
OTHER: Placebo

Sponsor

DiaMedica Therapeutics Inc